Publication Name	World Journal of Gastroenterology
Manuscript ID	119434
Country	South Korea

Category	Gastroenterology & Hepatology
Manuscript Type	Randomized Clinical Trial
Article Title	Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial
Manuscript Source	Unsolicited Manuscript
All Author List	Dong Soo Lee, Seung Woo Lee, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, Sae Hee Kim, Dong Kyu Lee, Ki Bae Kim, Sun Moon Kim, Young Sin Cho and Ju Seok Kim
Funding Agency and Grant Number	Funding Agency Grant Number Daewoong Pharmaceutical Co., Ltd. (Seoul, Korea)
Corresponding Author	Ju Seok Kim, Internal Medicine, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-Gu, Daejeon 35015, South Korea. showsik@hanmail.net
Key Words	Peptic ulcer; Potassium-competitive acid blocker; Proton pump inhibitors; Randomized controlled trial; Non-inferiority
Core Tip	Fexuprazan, a novel potassium-competitive acid blocker, has several advantages compare to proton pump inhibitors. Fexuprazan 40 mg showed non-inferiority in ulcer healing rate after 8 weeks in patients with peptic ulcer disease compared to rabeprazole 20 mg.
Citation	Lee DS, Lee SW, Kang SH, Moon HS, Sung JK, Kim SH, Lee DK, Kim KB, Kim SM, Cho YS, Kim JS. Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial. World J Gastroenterol 2026; In press

Received	2026-01-28 05:40
Peer-Review Started	2026-01-28 05:45
First Decision by Editorial Office Director	2026-03-12 08:51
Return for Revision	2026-03-12 08:51
Revised	2026-03-17 07:28
Publication Fee Transferred	2026-03-19 07:33
Second Decision by Editor	2026-04-09 02:32
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-04-09 06:00
Articles in Press	2026-04-09 06:00
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com